Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy

To mitigate the risk of stent thrombosis, patients treated by percutaneous coronary intervention (PCI) are administered dual anti-platelet therapy comprising aspirin and a platelet P2Y12 receptor inhibitor. Clopi...

Source: BMC Cardiovascular Disorders - June 3, 2020 Category: Cardiology Authors: Abdullah M. Al-Rubaish, Fahad A. Al-Muhanna, Abdullah M. Alshehri, Mohammed A. Al-Mansori, Rudaynah A. Alali, Rania M. Khalil, Khalid A. Al Faraidy, Cyril Cyrus, Mohammed M. Sulieman, Chittibabu Vatte, Daniel M. F. Claassens, Jurri ën M. ten Berg, Folker Tags: Study protocol Source Type: research